Technique to Measure ctDNA May Improve Metastatic Cancer Surveillance
Monitoring absolute ctDNA concentrations using a dual-threshold model may significantly improve metastatic cancer surveillance.
Read MorePosted by Chris Wolski | Feb 26, 2025 | Molecular Diagnostics |
Monitoring absolute ctDNA concentrations using a dual-threshold model may significantly improve metastatic cancer surveillance.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Unknown Origin & Other Cancer Types |
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 7, 2025 | Cancer |
A new biolaser-based method detects circulating tumor cells in pancreatic and lung cancer patients, improving early diagnosis and treatments.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Leukemia |
Researchers developed a groundbreaking blood test to personalize nanomedicine therapies for leukemia patients, improving treatments.
Read MorePosted by Andy Lundin | Dec 10, 2024 | Cancer, Molecular Diagnostics |
Researchers identified unique molecular “fingerprints” on ribosomes that can detect early-stage cancers using nanopore sequencing devices.
Read More